The
In a complaint filed in Washington federal court, the FTC said the deal would hinder innovation for medical devices used to treat a serious heart condition known as aortic regurgitation, where blood pumped from the heart leaks back into the chamber
JenaValve’s medical device was approved in the European Union and is expected to receive approval from the Food and Drug Administration later this year.
Edwards best known for its valve used to treat another condition, aortic stenosis, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.